BAT, GB0002875804

British American Tobacco stock (GB0002875804): Latest business updates

13.05.2026 - 14:02:56 | ad-hoc-news.de

British American Tobacco reported steady Q1 performance amid shifting consumer trends in tobacco and new categories. The stock has shown resilience for US investors tracking global consumer staples.

BAT, GB0002875804
BAT, GB0002875804

British American Tobacco plc released its first-quarter trading update, highlighting volume declines in combustible products offset by growth in new categories. Revenue from non-combustibles rose 17% on a constant currency basis, according to BAT Q1 2026 Trading Update as of 04/24/2026. This reflects ongoing transition efforts in a regulated industry.

The company maintained its full-year guidance, expecting adjusted diluted EPS of 390-410 pence. Shares traded at 2,450 GBp on 05/13/2026 on the London Stock Exchange, according to LSE data as of 05/13/2026. For US investors, BAT's ADR (NYSE: BTI) offers exposure to this FTSE 100 constituent.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: British American Tobacco plc
  • Sector/industry: Tobacco / Consumer Staples
  • Headquarters/country: London, UK
  • Core markets: US, Europe, Asia-Pacific, Emerging Markets
  • Key revenue drivers: Cigarettes, Vapes, Oral Nicotine
  • Home exchange/listing venue: London Stock Exchange (BATS)
  • Trading currency: GBP

Official source

For first-hand information on British American Tobacco, visit the company’s official website.

Go to the official website

British American Tobacco: core business model

British American Tobacco operates as a multinational tobacco company, producing cigarettes, smokeless products, and next-generation alternatives like vapes and heated tobacco. Its portfolio includes brands such as Lucky Strike, Dunhill, and Vuse. The firm generates over 90% of revenue from outside the UK, with a focus on high-margin emerging markets, per its 2025 Annual Report as of 02/28/2026.

The business model emphasizes a 'balanced growth' strategy: sustaining combustibles while scaling reduced-risk products (RRPs). In 2025, RRPs accounted for 18.4% of total revenue, up from 16.2% prior year. This shift targets health-conscious consumers amid global regulations.

Main revenue and product drivers for British American Tobacco

Combustible tobacco remains the largest driver, contributing 78% of 2025 group revenue at £25.7 billion for the year ended December 31, 2025, as reported in the annual results. Key brands like Pall Mall and Rothmans dominate in price-sensitive markets. US operations via Reynolds American contribute significantly, with Newport menthols leading domestic sales.

New categories are accelerating: Vuse vaping grew 12% in volumes, while Velo oral nicotine pouches expanded 28% in Q1 2026. These segments offer higher margins (up to 60%) versus traditional cigarettes (45%), supporting profitability. International markets like Brazil and Indonesia provide volume stability.

Industry trends and competitive position

The tobacco sector faces regulatory headwinds, including flavor bans and excise hikes, but BAT's RRP investments position it ahead of peers like Philip Morris. BAT holds 15% global combustible share and leads in US oral nicotine with Velo. Analogue declines averaged 7.5% in Q1 2026, industry-wide.

Competitive edges include a 170-country footprint and £4.5 billion RRP investment since 2017. For US investors, BAT's exposure to the world's largest tobacco market via BTI ADRs adds diversification against domestic pure-plays.

Why British American Tobacco matters for US investors

BAT's NYSE-listed ADR (BTI) provides US portfolios access to a 7% dividend yield and GBP strength. Reynolds American generates 35% of group profit, tying performance to US consumption trends. With $10 billion US nicotine pouch market growth projected by 2030 per S&P Global as of 03/15/2026, BAT captures key upside.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

British American Tobacco continues navigating industry challenges with RRP growth offsetting traditional declines. Q1 results affirm guidance amid macroeconomic pressures. US investors monitor regulatory shifts and US market dynamics for ongoing relevance.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis BAT Aktien ein!

<b>So schätzen die Börsenprofis BAT Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | GB0002875804 | BAT | boerse | 69323626 | bgmi